天津龙济医院泌尿外科医院男性专科天津市龙济泌尿专科预约,天津市武清区龙济男子医院怎么样,武清龙济医院治疗早泄到底多少钱啊,龙济医院男科泌尿科,龙济医院包皮手术义诊,天津省龙济泌尿专科医院,天津龙济医院泌尿外科口碑

WASHINGTON, Nov. 18 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Erwinaze to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy to E. coli derived asparaginase and pegapargase chemotherapy drugs used to treat ALL.Acute lymphoblastic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell. White blood cells help the body fight infection and are formed in the bone marrow.Erwinaze is injected directly into the muscle three times a week and works by breaking down one of the body's protein building blocks (the amino acid, asparagine) that is present in the blood, and is necessary for the growth of all cells. Leukemia cells cannot produce this protein building block. When a patient is treated with Erwinaze the leukemia cells die. Normal human cells are able to make enough asparagine for their own needs through biosynthesis and will not be affected by treatment with Erwinaze."The approval of Erwinaze underscores the FDA's commitment to the approval of drugs for conditions with limited patient populations with unmet medical needs using novel trial endpoints," said Richard Pazdur, director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research.Side effects associated with Erwinaze treatment include serious allergic reactions, inflammation of the pancreas, high blood levels of liver enzymes, blood clotting, bleeding, nausea, vomiting and high blood sugar.

KUNMING, Nov. 30 (Xinhua) -- More than 10,000 new HIV infections were reported in southwest China's Yunnan province during the first 10 months of this year, bringing the total number of HIV carriers and AIDS patients in the province to more than 90,000, local AIDS prevention authorities said Wednesday.As of Oct. 31, a total of 93,567 HIV infections had been reported in the province, with the disease claiming 14,340 lives, according to statistics from the Yunnan AIDS Prevention Bureau.The number of HIV infections contracted through sexual contact has been rising and sexual contact is now the main cause of the disease's proliferation, said Xu Heping, director of the bureau.Of the province's infected population, 45.8 percent contracted the disease through sexual contact, while 37.3 percent contracted the disease through intravenous drug abuse, according to the bureau.Sexually transmitted infections accounted for 77.3 percent of new infections during the January-October period, up from 71.3 percent during the same period last year, according to the statistics.Xu said this year's new infections mainly occurred in people between the ages of 20 and 39, accounting for 60.8 percent of the total.Infections among rural residents and unemployed people accounted for 55.3 percent and 18.6 percent, respectively, of this year's total, according to Xu.Lu Lin, director of the Yunnan disease control and prevention center, said migrant workers are particularly vulnerable to the disease due to their nomadic nature and lack of knowledge about the disease.China currently has 346,000 registered HIV carriers and AIDS patients, although the actual number is predicted to hit 780,000 by the end of this year, according to an expert panel consisting of members of China's Ministry of Health (MOH), the World Health Organization and UNAIDS.

YAGNON, Oct. 23 (Xinhua) -- Myanmar has launched anti-dengue high fever campaign in seven townships in Yangon simultaneously as a prevention measure against the disease, according to the Health Department Sunday.The campaign was carried out in the weekend in collaboration with health department staff and members of social organizations.Dengue preventive and control measures were occasionally launched in schools and wards in Myanmar with the aid of World Health Organization, U.N. Children Fund, three Disease Fund, Global Fund and Japan International Cooperation Agency.According to statistics, a total of 181 people died of dengue fever in Myanmar's Yangon region in the past five years alone, out of 19,000 such cases occurring in the region during the half decade.According to earlier report, the number of people infected with dengue fever in the whole country in 2009 amounted to 3,129 with 37 deaths registered.However, according to the Yangon City Development Committee, the city saw less dengue fever occurrence in 2010 with death rate reducing to one percent in the year from over six percent in 1970.Meanwhile, the Myanmar health authorities are stepping up preventive measures against dengue fever in this sensitive rainy season by extending injection to people.The authorities are also introducing medicine with better effect, combating larva, giving education talks on the prevention and control especially in markets.Dengue fever mostly infected under-15 children, especially those between three and nine years old, but now such disease had also been found among some adult people, the authorities said, warning that dengue fever occurs regardless of age and season.Myanmar, along with Indonesia and Thailand, suffers dengue outbreak most in Southeast Asia region that makes up 52 percent of the dengue-prone areas in the world.

BEIJING, Jan. 21 (Xinhua) -- The State Grid Corporation of China (SGCC), the country's largest electric power transmission and distribution company, said Saturday that the power supply will be sufficient during the upcoming Spring Festival holiday.Thermal power plants currently have 89.34 million tonnes of coal, which is enough for 20 days of power generation.Meanwhile, the country's electricity consumption is expected to fall by 40 percent during the holiday which lasts from Jan. 22 to Jan. 28, as many factories suspend production during the period, SGCC said.The company said it will keep a close eye on the cold weather, strengthen inspections and maintenance of high-voltage grids, and take precautions to minimize the impact of snow and freezing rain on power transmission.